Patents by Inventor Qinglong Guo

Qinglong Guo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polycyclic substituted pyrazole kinase activity inhibitors and use thereof
    Patent number: 9550792
    Abstract: The present invention relates to the field of medicinal chemistry, and in particular relates to 4-(five-membered heterocyclic pyrimidine/pyridine substituted) amino-1H-3-pyrazolecarboxamide derivatives, the preparation method thereof, pharmaceutical compositions containing these compounds and the medicinal use thereof, especially as protein kinase inhibitors for anti-tumor use.
    Type: Grant
    Filed: January 7, 2014
    Date of Patent: January 24, 2017
    Assignee: SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO., LTD.
    Inventors: Tao Lu, Yue Wang, Yadong Chen, Yi Lu, Zhanwei Wang, Qiaomei Jin, Taotao Yang, Guowu Lin, Qinglong Guo, Li Zhao
  • Polycyclic Substituted Pyrazole Kinase Activity Inhibitors and Use Thereof
    Publication number: 20150368259
    Abstract: The present invention relates to the field of medicinal chemistry, and in particular relates to 4-(five-membered heterocyclic pyrimidine/pyridine substituted) amino-1H-3-pyrazolecarboxamide derivatives, the preparation method thereof, pharmaceutical compositions containing these compounds and the medicinal use thereof, especially as protein kinase inhibitors for anti-tumour use.
    Type: Application
    Filed: January 7, 2014
    Publication date: December 24, 2015
    Inventors: Tao LU, Yue Wang, Yadong Chen, Yi Lu, Zhanwei Wang, Qiaomei Jin, Taotao Yang, Guowu Lin, Qinglong Guo, Li Zhao
  • derivative, its preparing method and medicinal use
    Patent number: 8501803
    Abstract: The present invention relates to a field of pharmaceutical chemistry, more specifically, the present invention relates to a garcinia derivative Formula (I), its preparing method, and medicinal use. Wherein the definitions of R1 and R2 are disclosed in the specification of the present invention, and the derivative of the present invention is a structurally simplified analogue of the gambogic acid compound; wherein the gambogic acid compound possesses anti-cancer characteristics, and could be used for preparation of anti-tumor drugs.
    Type: Grant
    Filed: November 9, 2010
    Date of Patent: August 6, 2013
    Assignee: China Pharmaceutical University
    Inventors: Qidong You, Xiaojian Wang, Qian Yang, Na Lu, Changjun Lin, Qinglong Guo
  • GARCINIA DERIVATIVE, ITS PREPARING METHOD AND MEDICINAL USE
    Publication number: 20120059050
    Abstract: The present invention relates to a field of pharmaceutical chemistry, more specifically, the present invention relates to a garcinia derivative Formula (I), its preparing method, and medicinal use. Wherein the definitions of R1 and R2 are disclosed in the specification of the present invention, and the derivative of the present invention is a structurally simplified analogue of the gambogic acid compound; wherein the gambogic acid compound possesses anti-cancer characteristics, and could be used for preparation of anti-tumor drugs.
    Type: Application
    Filed: November 9, 2010
    Publication date: March 8, 2012
    Inventors: Qidong You, Xiaojian Wang, Qian Yang, Na Lu, Changjun Lin, Qinglong Guo